Description:

GOG-0241 Surgical Reporting Form (C) NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D1826DA-E8EB-F792-E040-BB89AD433BF7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D1826DA-E8EB-F792-E040-BB89AD433BF7
Keywords:
  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 7/3/15 7/3/15 -
Uploaded on:

July 3, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GOG-0241 Surgical Reporting Form (C) NCT01081262

No Instruction available.

  1. StudyEvent: GOG-0241 Surgical Reporting Form (C)
    1. No Instruction available.
Header Module
Surgery assessment
Operative procedure performed (check all that apply)
Surgical approach
Stage
%
Residual gross tumor
cm
Microscopic disease only
Ascites
Cytology of peritoneal or ascitic fluids
Summary of operative findings
Exam
Proc
Comments

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial